✦ LIBER ✦

Bevacizumab AVAiLs in non-small cell lung cancer

Book ID: 120847209
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2007
Weight: 179 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200715930-00025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9172 Analysis of biomarkers (BMs) in the

9172 Analysis of biomarkers (BMs) in the AVAiL phase III randomised study of first-line Bevacizumab (Bv) with cisplatin-gemcitabine (CG) in patients (pts) with non-small cell lung cancer (NSCLC)

✍ Leighl, N.; Reck, M.; de Haas, S.; Evers, S.; Delmar, P.; Manegold, C.; Scherer, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Bevacizumab in Non-Small Cell Lung Cance

Bevacizumab in Non-Small Cell Lung Cancer

✍ Dr Francesco Di Costanzo, Francesca Mazzoni, Marinella Micol Mela, Lorenzo Anton 📂 Article 📅 2008 🏛 Springer International Publishing AG 🌐 English ⚖ 114 KB

Bevacizumab in non-small-cell lung cance

Bevacizumab in non-small-cell lung cancer: a review

✍ Planchard, David 📂 Article 📅 2011 🏛 Expert Reviews 🌐 English ⚖ 901 KB

Bevacizumab enhances chemo for non-small

Bevacizumab enhances chemo for non-small cell lung cancer

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Bevacizumab in the treatment of non-smal

Bevacizumab in the treatment of non-small-cell lung cancer

✍ Stinchcombe, T E; Socinski, M A 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 140 KB

Emerging Safety Data for Bevacizumab in

Emerging Safety Data for Bevacizumab in Advanced Non–Small-Cell Lung Cancer

✍ Vera Hirsh 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 155 KB